Cyclosporin galenic forms

Details Cyclosporin galenic forms Cyclosporin galenic forms

1998-03-24

1999-11-02

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514785, 514786, A61K 3813, A61K 4714

Patent

active

059770660

ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.

REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 4108985 (1978-08-01), Ruegger et al.
patent: 4210581 (1980-07-01), Ruegger et al.
patent: 4220641 (1980-09-01), Traber et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4719239 (1988-01-01), Muller et al.
patent: 5338761 (1994-08-01), Nakajima et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5652212 (1997-07-01), Cavanak et al.
patent: 5759997 (1998-06-01), Cavanak
Cavanak, T., et al., Prog. Allergy, vol. 38, pp. 65-72, (1986).
Chemical Abstracts, 89: 117875t (Jun. 8, 1978).
Chemical Abstracts, 89: 117874s (Jun. 8, 1978).
Chemical Abstracts, 92: 64765k (Sep. 13, 1979).
Derwent Abstracts, 84-069426/12 (Feb. 19, 1984).
Miglyol-Neutral Oil, Dynamit Nobel Chemicals (1975).
Reymond, J., et al., Pharmaceutical Research, vol. 5, No. 10., pp. 673-676, (1988).
Reymond, J., University of Basel, (1986). Dissertation: In Vitro In Vivo Model For The Absorption of Cyclosporin A.

Affiliated with

Also associated with

Rating

Cyclosporin galenic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin galenic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin galenic forms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2135509